# Langer mesomelic dysplasia

**Langer mesomelic dysplasia** (LMD) is an uncommon inherited bone growth disorder in which both working copies of the [SHOX](https://www.edgepedia.org/shox) gene are missing, producing markedly disproportionate short stature along with mesomelic and rhizomelic shortening affecting both the arms and the legs<sup>[1](https://www.orpha.net/en/disease/detail/2632)</sup>. It is the homozygous or compound heterozygous, more severe counterpart of [Léri-Weill dyschondrosteosis](https://www.edgepedia.org/leri-weill-dyschondrosteosis), in which only one SHOX copy is affected<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup>. The condition is present before birth (antenatal onset) and is listed as OMIM 249700 and ORPHA:2632<sup>[1](https://www.orpha.net/en/disease/detail/2632)</sup>.

| Key fact | Detail |
|---|---|
| Definition | Rare genetic skeletal dysplasia with severe disproportionate short stature and mesomelic and rhizomelic limb shortening<sup>[1](https://www.orpha.net/en/disease/detail/2632)</sup> |
| Cause | Biallelic (homozygous or compound heterozygous) pathogenic SHOX variants producing SHOX nullizygosity<sup>[3](https://www.ncbi.nlm.nih.gov/sites/books/NBK279130/)</sup> |
| Inheritance | Pseudoautosomal recessive; SHOX lies in the pseudoautosomal region present on both the X and Y chromosomes<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup> |
| Prevalence | Point prevalence below 1 in 1,000,000; Orphanet records more than 100 described cases, while a 2026 review counts fewer than one hundred<sup>[1](https://www.orpha.net/en/disease/detail/2632)</sup><sup> • </sup><sup>[4](https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2026.1876732/full)</sup> |
| Height | Final adult heights reported between −4.2 and −8.9 SDS in a series of 15 cases<sup>[3](https://www.ncbi.nlm.nih.gov/sites/books/NBK279130/)</sup> |
| Age of onset | Antenatal<sup>[1](https://www.orpha.net/en/disease/detail/2632)</sup> |
| Prognosis | Cognitive development and life expectancy are generally preserved<sup>[4](https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2026.1876732/full)</sup> |

## Clinical features

Affected individuals have extreme shortening of the long bones of the arms and legs (mesomelia), producing very short stature<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup>. The ulna in the forearm and the fibula in the lower leg are often underdeveloped or absent, while the radius and tibia are unusually short, thick, and curved<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup>. The Orphanet clinical description also lists a malformed humeral head, a radially bowed shaft, distorted carpal bones, a shortened femoral neck, and a proximal fibular half that is either missing or underdeveloped<sup>[5](https://www.orpha.net/en/disease/detail/2632?mode=name&search=)</sup>.

The disorder presents at birth with severely shortened long bones involving both the middle and proximal limb segments<sup>[5](https://www.orpha.net/en/disease/detail/2632?mode=name&search=)</sup>. Additional features include hypoplasia of the mandible and micrognathia, short fingers, and broad hands<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup><sup> • </sup><sup>[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC1180673/)</sup>. [Madelung deformity](https://www.edgepedia.org/madelung-deformity), a wrist and forearm abnormality, is typically not part of LMD according to the Endotext skeletal dysplasias chapter<sup>[3](https://www.ncbi.nlm.nih.gov/sites/books/NBK279130/)</sup>, although MedlinePlus states that some affected individuals do have it, where it may cause pain and limit wrist movement<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup>. Orphanet lists Madelung deformity among the very frequent clinical signs<sup>[7](https://www.orpha.net/en/disease/sign/2632)</sup>.

Growth failure is severe. A series described by Fukami and colleagues reported 15 cases of LMD with final adult heights ranging from −4.2 to −8.9 SDS, meaning between 4.2 and 8.9 standard deviations below the population mean for age<sup>[3](https://www.ncbi.nlm.nih.gov/sites/books/NBK279130/)</sup>. An earlier review gave a height range of −5.5 to −8.9 SDS<sup>[8](https://pmc.ncbi.nlm.nih.gov/articles/PMC4971310/)</sup>.

## The SHOX gene and mechanism

LMD results from changes involving the SHOX (short stature homeobox) gene, which lies in the pseudoautosomal region 1 (PAR1) at Xp22.33/Yp11.32<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup><sup> • </sup><sup>[9](https://pmc.ncbi.nlm.nih.gov/articles/PMC3400739/)</sup>. The SHOX protein is a homeodomain-containing transcription factor important for chondrocyte proliferation, differentiation, and growth plate organization, and it is particularly important for the growth and maturation of the limb bones<sup>[4](https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2026.1876732/full)</sup><sup> • </sup><sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup>.

The most common cause is a deletion of the entire SHOX gene; other causes include mutations within the gene and deletions of nearby regulatory material that normally controls its activity<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup>. Across SHOX-related disorders, deletions of the gene or its downstream enhancers account for about 90% of identified mutations<sup>[9](https://pmc.ncbi.nlm.nih.gov/articles/PMC3400739/)</sup>. All of these changes greatly reduce or eliminate SHOX protein production, and this lack of protein disrupts normal bone development<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup>.

## Inheritance and family risk

Because SHOX sits in the pseudoautosomal region, it is present on both sex chromosomes, so both females (two X chromosomes) and males (one X and one Y) normally carry two functional copies<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup>. The disorder follows a pseudoautosomal recessive pattern: in females both X-chromosome copies must be missing or altered, and in males both the X and the Y copy must be affected<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup>.

Heterozygous carriers, who have one affected copy, instead show Léri-Weill dyschondrosteosis, a similar but typically less severe disorder marked by short stature, mesomelia, and Madelung deformity of the forearm<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup><sup> • </sup><sup>[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC1180673/)</sup>. Several couples in which both members have Léri-Weill dyschondrosteosis have had children with LMD<sup>[8](https://pmc.ncbi.nlm.nih.gov/articles/PMC4971310/)</sup>. GeneReviews quantifies the risk when both parents have SHOX deficiency: each offspring has a 50% chance of having a SHOX deficiency disorder, a 25% chance of having the Langer type of mesomelic dwarfism, and a 25% chance of having neither condition<sup>[10](https://www.ncbi.nlm.nih.gov/books/NBK1215/pdf/Bookshelf_NBK1215.pdf)</sup>.

## Diagnosis and frequency

Diagnosis can be established from clinical and X-ray features, including mesomelic disproportion of the limbs; genetic testing confirms the clinical diagnosis and supports prognosis and counseling<sup>[9](https://pmc.ncbi.nlm.nih.gov/articles/PMC3400739/)</sup>. Prenatal diagnosis is technically feasible and, among the SHOX-related conditions, is recommended only for LMD<sup>[9](https://pmc.ncbi.nlm.nih.gov/articles/PMC3400739/)</sup>.

The exact prevalence is unknown. Orphanet gives a point prevalence below 1 in 1,000,000 and states that more than 100 cases have been described, most from populations with a high level of consanguinity<sup>[1](https://www.orpha.net/en/disease/detail/2632)</sup><sup> • </sup><sup>[5](https://www.orpha.net/en/disease/detail/2632?mode=name&search=)</sup>. MedlinePlus reports that several dozen affected individuals have appeared in the scientific literature<sup>[2](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)</sup>, and a 2026 narrative review by Piwar and colleagues counts fewer than one hundred documented cases<sup>[4](https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2026.1876732/full)</sup>. LMD has a higher prevalence in populations with a high incidence of consanguinity<sup>[9](https://pmc.ncbi.nlm.nih.gov/articles/PMC3400739/)</sup>.

## History

Leonard Langer first described the condition in 1967, and it was later shown to result from homozygous loss of SHOX<sup>[3](https://www.ncbi.nlm.nih.gov/sites/books/NBK279130/)</sup>. The molecular link was established in 1998, when Belin and colleagues showed large-scale SHOX deletions and a nonsense mutation in families with dyschondrosteosis and demonstrated that Langer mesomelic dwarfism results from homozygous mutations at the same locus<sup>[11](https://www.nature.com/articles/ng0598-67)</sup>. Early molecular confirmation came from affected fetuses: a 24-week fetus with a 45,X karyotype and a SHOX-encompassing microdeletion on its single [X chromosome](https://www.edgepedia.org/x-chromosome) was nullizygous for SHOX, and other fetuses carried deletions inherited from both parents<sup>[12](https://pmc.ncbi.nlm.nih.gov/articles/PMC13436952/)</sup>.

## References

1. [Langer mesomelic dysplasia, Orphanet ORPHA:2632](https://www.orpha.net/en/disease/detail/2632)
2. [Langer mesomelic dysplasia, MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/langer-mesomelic-dysplasia/)
3. [Skeletal Dysplasias, Endotext, NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/sites/books/NBK279130/)
4. [Piwar H, Pawlasek J, Sielaff P, Sztachelska M, Ordak M (2026). Langer mesomelic dysplasia as a rare manifestation of SHOX deficiency: a narrative review. Frontiers in Genetics 17:1876732](https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2026.1876732/full)
5. [Orphanet disease detail: Langer mesomelic dysplasia (clinical description)](https://www.orpha.net/en/disease/detail/2632?mode=name&search=)
6. [Genetic Disorders of the Skeleton: A Developmental Approach, PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC1180673/)
7. [Orphanet clinical signs and symptoms, ORPHA:2632](https://www.orpha.net/en/disease/sign/2632)
8. [A Track Record on SHOX: From Basic Research to Complex Models and Therapy, PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC4971310/)
9. [Clinical utility gene card for: Leri-Weill dyschondrosteosis (LWD) and Langer mesomelic dysplasia (LMD), PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC3400739/)
10. [SHOX Deficiency Disorders, GeneReviews, NCBI Bookshelf PDF](https://www.ncbi.nlm.nih.gov/books/NBK1215/pdf/Bookshelf_NBK1215.pdf)
11. [Belin V et al. (1998). SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nature Genetics 19:67–69](https://www.nature.com/articles/ng0598-67)
12. [Langer mesomelic dysplasia as a rare manifestation of SHOX deficiency: a narrative review, PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC13436952/)

---
*Topic: Encyclopedia › Life and health › Human health and medicine › Diseases and injuries › Skin and musculoskeletal conditions › Musculoskeletal conditions › Bone disease and injury › Acromelic and mesomelic dysplasias*

*Initially written Oct 21, 2026*

*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*

License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license
